Trial Profile
Molecular Mechanisms of Antipsychotic-induced Insulin Resistance in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 03 Nov 2023
Price :
$35
*
At a glance
- Drugs Olanzapine (Primary)
- Indications Aggression; Bipolar depression; Bipolar disorders; Huntington's disease; Major depressive disorder; Manic episodes; Schizophrenia
- Focus Pharmacodynamics
- 27 Oct 2023 Status changed from active, no longer recruiting to completed.
- 11 Jul 2022 Status changed from recruiting to active, no longer recruiting.
- 21 May 2019 The study phase was changed from phase 2 to phase 0, according to Clinicaltrials.gov record.